-
2022-502779-40-99
5
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
-
2024-516284-90-00
5
rhinosinusitis not requiring antibiotic therapy
-
2024-520446-31-00
5
2026-05-27
Participants with overweight or obesity, and type 2 diabetes
-
2025-523533-25-00
10
2026-03-26
Cancer-associated Cachexia
-
2024-519423-24-00
5
2025-10-07
Major Depressive Disorder
-
2023-509606-30-00
5
2024-07-24
Ulcerative colitis
-
2025-523283-21-00
5
2026-02-17
Peripheral Arterial Disease
-
2025-521892-30-00
5
2025-11-24
Primary isolated CABG patients with stable coronary artery disease (ch
-
2025-520690-39-00
4
2025-11-04
Moderately to Severely Active Ulcerative Colitis (UC)
-
2024-519418-29-00
5
2025-09-19
Major Depressive Disorder
-
2023-509070-36-00
5
2025-03-18
Major Depressive Disorder with Insomnia Symptoms
-
2024-511652-40-00
5
2025-02-05
METASTATIC CASTRATION RESISTANT PROSTATE CANCER
-
2023-510128-66-00
5
2024-09-02
Participants with treatment-naïve metastatic squamous Non-small Cell L
-
2023-504899-25-00
5
2024-04-04
Metastatic castration resistant prostate cancer
-
2023-504031-41-00
5
2024-03-25
ER+/HER2- Early Breast Cancer
-
2023-503376-24-00
5
2024-03-20
Metastatic non-small cell lung cancer (NSCLC)
-
2024-517628-20-00
11
2023-10-24
hypertension
-
2024-517206-28-00
6
2022-09-21
Recent myocardial infarction associated with iron deficient
-
2025-521067-13-00
5
2026-04-24
Atherosclerotic Cardiovascular Disease (ASCVD)
-
2024-512925-95-00
5
2025-05-16
Advanced/Metastatic Breast Cancer
-
2024-511650-50-00
5
2025-01-17
METASTATIC CASTRATION RESISTANT PROSTATE CANCER
-
2023-509190-23-00
5
2024-09-03
Atherosclerotic Cardiovascular Disease
Elevated lp(a)
-
2022-502442-27-00
5
2024-01-08
Obesity
-
2022-502779-40-00
5
2023-09-04
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)